Fingerprint
Dive into the research topics of 'High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial
Karen Schreiber, Melinda Magyari, Finn Sellebjerg, Pernille Iversen, Ellen Garde, Camilla Gøbel Madsen, Lars Börnsen, Jeppe Romme Christensen, Rikke Ratzer, Hartwig Roman Siebner, Bjarne Laursen, Per Soelberg Sorensen